Postoperative GnRH analog treatment for the prevention of recurrences of uterine myomas after myomectomy. A pilot study

Gynecol Obstet Invest. 1997;43(4):251-4. doi: 10.1159/000291867.

Abstract

Sixty-five patients with uterine myomas were studied after surgery to investigate the effect of periodic GnRH analog treatment on the prevention of recurrences. A group of patients was treated by leuprolide acetate depot 3 months a year for 3 years. At the end of treatment, these patients showed a significantly reduced uterine volume and myoma recurrence rate as compared to untreated patients. A role of GnRH analogs in the clinical prevention of myoma recurrence could be suggested.

MeSH terms

  • Adult
  • Delayed-Action Preparations
  • Female
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Humans
  • Incidence
  • Leiomyoma / epidemiology
  • Leiomyoma / prevention & control*
  • Leiomyoma / surgery*
  • Leuprolide / administration & dosage
  • Leuprolide / pharmacology*
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / prevention & control*
  • Pilot Projects
  • Postoperative Care*
  • Ultrasonography
  • Uterine Neoplasms / epidemiology
  • Uterine Neoplasms / prevention & control*
  • Uterine Neoplasms / surgery*
  • Uterus / diagnostic imaging
  • Uterus / pathology

Substances

  • Delayed-Action Preparations
  • Gonadotropin-Releasing Hormone
  • Leuprolide